GlassScriptPhysician profile
Caesar C Butura
NPI 1578668042
$27,002.51
in general payments reported to CMS, 2019-2025
9 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,852 · 2020: $16K · 2021: $34.59 · 2022: $175 · 2023: $631 · 2024: $347 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037 · Gift: $246 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $61.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.46 |
| Gift | $246.01 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $61.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $26,301.33 | 2019-2025 | |
| Nobel Biocare USA | $378.82 | 2019-2023 | Nobelactive |
| Ultradent Products INC | $148.98 | 2025 | Opalescence |
| Biohorizons Implant Systems INC. | $57.92 | 2019 | |
| Vertical Pharmaceuticals, LLC | $35.26 | 2023 | Dsuvia |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $32.42 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $21.35 | 2022 | |
| Kls-Martin L.P. | $15.03 | 2023 | |
| Keystone Dental INC. | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caesar Butura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.